CPHI logo

China Pharma Holdings, Inc.

CPHI
Healthcare|Drug Manufacturers - Specialty & Generic|CN
$0.57
+0.04 (+7.53%)
Cash / Share
$0.07
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Jul 23, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (6)

Apr 2027
Est. completion
P1Chronic Weight Management
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight
NCT07893106n=86
Jun 2027
Est. completion
P1Chronic Weight Management
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight
NCT07893093n=144
Jun 2027
Est. completion
P1Chronic Weight Management
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight
NCT07842640n=84
Jun 2028
Est. completion
P3HPV InfectioN
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 18-45 Years
NCT05262010n=13,500
Jul 2028
Est. completion
P3Obesity
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT07743463n=3,003
Jul 2028
Est. completion
P3Obesity
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT07743450n=1,560

Recent Press Releases

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026
Oct 6, 2026 · Business Wire
Lifecore Biomedical to Participate at CPHI Global Conference
Sep 3, 2026 · GlobeNewsWire

SEC Filings (25)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Jul 23, 2026424B5Offering prospectusDocumentIndex
Jul 22, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
Apr 1, 202610-KAnnual reportDocumentIndex
Apr 1, 2026NT 10-KDocumentIndex
Mar 3, 20268-KMaterial eventDocumentIndex
Feb 10, 20268-KMaterial eventDocumentIndex
Jan 6, 20268-KMaterial eventDocumentIndex
Dec 23, 20258-KMaterial eventDocumentIndex
Dec 10, 20258-KMaterial eventDocumentIndex
Nov 14, 2025DEF 14AProxy / shareholder voteDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 4, 2025PRE 14AProxy / shareholder voteDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex
Apr 4, 20258-KMaterial eventDocumentIndex
Mar 31, 202510-KAnnual reportDocumentIndex
Dec 26, 20248-KMaterial eventDocumentIndex
Dec 26, 20248-KMaterial eventDocumentIndex
Dec 13, 20248-KMaterial eventDocumentIndex
Dec 13, 2024424B5Offering prospectusDocumentIndex
Nov 13, 202410-QQuarterly reportDocumentIndex
Nov 12, 2024DEF 14AProxy / shareholder voteDocumentIndex